Overt Hepatic Encephalopathy Companies

ID: MRFR/Pharma/0280-HCR

95 Pages

Nidhi Mandole

Last Updated: February 16, 2025

Overt hepatic encephalopathy refers to the advanced stage of hepatic encephalopathy, a condition associated with liver dysfunction. Companies involved in overt hepatic encephalopathy may focus on developing pharmaceuticals or medical interventions to manage and treat this serious neurological complication of liver disease.

Overt Hepatic Encephalopathy Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.43%

2024 Market Size$ 1.74 Billion

2025 Market Size$ 1.82 Billion

2035 Market Size$ 2.8 Billion

Key Players

AbbVie Inc

Bristol-Myers Squibb Company

Horizon Therapeutics plc

Mylan N.V.

Fresenius Kabi AG

Amgen Inc

Trends

Rising Awareness and Education
Technological Integration in Treatment
Research Advancements in Therapeutics

Opportunities

Advancements in Diagnostic Techniques
Increasing Prevalence of Liver Diseases
Regulatory Support for Innovative Therapies

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Overt Hepatic Encephalopathy Market

Latest North America Microarray Companies Updates

VEDANTA BIOSCIENCES: Phase 3 trial (PEARL) evaluating VE303, a novel gut-selective antibiotic, met its primary endpoint of reducing the frequency of OHE episodes in patients with cirrhosis compared to placebo. This is a significant step towards potentially offering a new treatment option for OHE.

AXCELLA HEALTH: Positive top-line data from Phase 2b trial of AXA1665, a gut-selective antibiotic, showed a trend towards reducing OHE events and improving cognitive function in patients with cirrhosis. Phase 3 trials are planned.

SALIX PHARMACEUTICALS: Ongoing observational study evaluating the real-world effectiveness of rifaximin in preventing OHE recurrence in patients with cirrhosis. Results are expected to provide valuable insights into long-term treatment strategies.

List of North America Microarray Key companies in the market:

Alfa Wassermann S.P.A
Cosmo Pharmaceuticals S.P.A
Horizon Pharma Plc.
KannaLife Sciences, Inc.
Ocer Therapeutics
Rebiotix Inc.
Spherium Biomed S.L
Umecrine Cognition AB
ASKA Pharmaceutical
Mallinckrodt
Valeant

Customize Report

Certified Researchers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”